200 related articles for article (PubMed ID: 15844093)
1. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.
Kontoyiannis DP; Boktour M; Hanna H; Torres HA; Hachem R; Raad II
Cancer; 2005 Jun; 103(11):2334-7. PubMed ID: 15844093
[TBL] [Abstract][Full Text] [Related]
2. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
[TBL] [Abstract][Full Text] [Related]
3. Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B.
Kontoyiannis DP; Andersson BS; Lewis RE; Raad II
Clin Infect Dis; 2001 Mar; 32(5):E94-6. PubMed ID: 11229866
[TBL] [Abstract][Full Text] [Related]
4. [Curative treatment of invasive aspergillosis].
Dupont B
Pathol Biol (Paris); 1994 Sep; 42(7):688-93. PubMed ID: 7877863
[TBL] [Abstract][Full Text] [Related]
5. Treatment and outcome of invasive Aspergillus infections in allogeneic BMT recipients.
Jantunen E; Ruutu P; Piilonen A; Volin L; Parkkali T; Ruutu T
Bone Marrow Transplant; 2000 Oct; 26(7):759-62. PubMed ID: 11042657
[TBL] [Abstract][Full Text] [Related]
6. Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID Mycoses Study Group criteria.
Stevens DA; Lee JY
Arch Intern Med; 1997 Sep; 157(16):1857-62. PubMed ID: 9290545
[TBL] [Abstract][Full Text] [Related]
7. [Aspergillosis in pulmonary transplantation].
de Pablo A; Ussetti P; Cruz Carreño M; Lázaro T; Ferreiro MJ; López A; Mendaza P; Estada J
Enferm Infecc Microbiol Clin; 2000 May; 18(5):209-14. PubMed ID: 10974763
[TBL] [Abstract][Full Text] [Related]
8. [Invasive aspergillosis on a surgical intensive care unit].
Kujath P; Klempien I; Muhl E; Kämmerer R
Mycoses; 2000; 43 Suppl 2():23-7. PubMed ID: 11291572
[TBL] [Abstract][Full Text] [Related]
9. Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: a European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the Intergroupe Français du Myélome.
Lortholary O; Ascioglu S; Moreau P; Herbrecht R; Marinus A; Casassus P; De Pauw B; Denning DW
Clin Infect Dis; 2000 Jan; 30(1):41-6. PubMed ID: 10619731
[TBL] [Abstract][Full Text] [Related]
10. Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.
Petraitiene R; Petraitis V; Groll AH; Sein T; Piscitelli S; Candelario M; Field-Ridley A; Avila N; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 2001 Mar; 45(3):857-69. PubMed ID: 11181372
[TBL] [Abstract][Full Text] [Related]
11. Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
Myoken Y; Sugata T; Kyo T; Fujihara M; Mikami Y
J Periodontol; 2002 Jan; 73(1):33-8. PubMed ID: 11846198
[TBL] [Abstract][Full Text] [Related]
12. [Curative antifungal treatment of invasive pulmonary aspergillosis].
Andrès E; Courouau F; Kurtz JE; Limacher JM; Quoix E
Rev Pneumol Clin; 1995; 51(4):228-31. PubMed ID: 7501940
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients.
Nucci M; Biasoli I; Akiti T; Silveira F; Solza C; Barreiros G; Spector N; Derossi A; Pulcheri W
Clin Infect Dis; 2000 Feb; 30(2):300-5. PubMed ID: 10671332
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.
Denning DW; Ribaud P; Milpied N; Caillot D; Herbrecht R; Thiel E; Haas A; Ruhnke M; Lode H
Clin Infect Dis; 2002 Mar; 34(5):563-71. PubMed ID: 11807679
[TBL] [Abstract][Full Text] [Related]
15. Amphotericin B with and without itraconazole for invasive aspergillosis: A three-year retrospective study.
Popp AI; White MH; Quadri T; Walshe L; Armstrong D
Int J Infect Dis; 1999; 3(3):157-60. PubMed ID: 10460928
[TBL] [Abstract][Full Text] [Related]
16. Scedosporium infection in immunocompromised patients: successful use of liposomal amphotericin B and itraconazole.
Barbaric D; Shaw PJ
Med Pediatr Oncol; 2001 Aug; 37(2):122-5. PubMed ID: 11496350
[TBL] [Abstract][Full Text] [Related]
17. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
Patterson TF; Kirkpatrick WR; White M; Hiemenz JW; Wingard JR; Dupont B; Rinaldi MG; Stevens DA; Graybill JR
Medicine (Baltimore); 2000 Jul; 79(4):250-60. PubMed ID: 10941354
[TBL] [Abstract][Full Text] [Related]
18. [Antimycotic treatment of pulmonary aspergilloma in patients without neutropenia].
Grysczyk H; De Roux A; Grassot A; Mauch H; Lode H
Dtsch Med Wochenschr; 2002 Mar; 127(10):492-6. PubMed ID: 11884987
[TBL] [Abstract][Full Text] [Related]
19. [Role of chemoprophylaxis in the prevention of invasive aspergillosis].
Joly V
Pathol Biol (Paris); 1994 Sep; 42(7):694-9. PubMed ID: 7877864
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of invasive aspergillosis with itraconazole: our own experiences and review of the literature].
Kreisel W
Mycoses; 1994; 37 Suppl 2():42-51. PubMed ID: 7609743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
